Literature DB >> 32878503

Effects of 12-week aerobic exercise on patient-reported outcomes in women with systemic lupus erythematosus.

Blanca Gavilán-Carrera1, José Antonio Vargas-Hitos2, Pablo Morillas-de-Laguno3, Antonio Rosales-Castillo2, Sergio Sola-Rodríguez4, José Luis Callejas-Rubio5, José Mario Sabio2, Alberto Soriano-Maldonado4,6.   

Abstract

PURPOSE: To evaluate the effects of aerobic exercise on patient-reported outcomes (PROs) in women with systemic lupus erythematosus (SLE), and whether changes in cardiorespiratory fitness (CRF) mediate the changes in PROs.
METHODS: A total of 58 women with SLE were assigned to either an exercise group (EG; n = 26) or a control group (CG; n = 32) in this non-randomized clinical trial. The EG comprised 12 weeks of aerobic exercise (2 sessions/week) between 40%-75% of the individual's heart rate reserve. At baseline, and at week 12, CRF (Bruce test) and PROs were assessed including psychological stress (Perceived Stress Scale), sleep quality (Pittsburg Sleep Quality Index), fatigue (Multidimensional Fatigue Inventory), depressive symptoms (Beck Depression Inventory), and quality of life (36-item Short-Form Health Survey).
RESULTS: In comparison to the CG, the EG showed a significant reduction in general fatigue (mean difference (MD) -2.86 units; 95%CI -5.70 to -0.01; p = 0.049), physical fatigue (MD -4.33 units; 95%CI -7.02 to -1.65; p = 0.002) and a non-significant reduction of reduced motivation (MD - 1.29 units; 95%CI -2.60 to 0.03; p = 0.055). There were no significant between-group differences in the changes in psychological stress, sleep quality, depressive symptoms, quality of life, or other fatigue dimensions (all p > 0.05). Changes in CRF mediated the effects of the exercise intervention on general fatigue by 53.8%.
CONCLUSION: The results suggest that 12 weeks of progressive aerobic exercise might improve relevant dimensions of fatigue in women with SLE, despite the absence of effects on other PROs. Improvements in CRF seem to mediate the effect of exercise on general fatigue.Implications for rehabilitationAerobic exercise could be safely introduced in rehabilitation programs for inactive patients with SLE with mild disease activity.Including physical activity recommendations as part of rehabilitation could improve relevant aspects of fatigue in women with SLE.When rehabilitation aims at reducing fatigue, cardiorespiratory fitness improvements derived from physical activity might enhance benefits.

Entities:  

Keywords:  Physical activity; SLE; aerobic capacity; fatigue; mental health; quality of life

Mesh:

Year:  2020        PMID: 32878503     DOI: 10.1080/09638288.2020.1808904

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   2.439


  4 in total

Review 1.  A glimpse into the future of systemic lupus erythematosus.

Authors:  Martin Aringer; Marta E Alarcón-Riquelme; Megan Clowse; Guillermo J Pons-Estel; Edward M Vital; Maria Dall'Era
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-03-30       Impact factor: 5.346

2.  Predictors of stress in patients with Lupus.

Authors:  Meenakshi Jolly; Patricia Katz
Journal:  Front Med (Lausanne)       Date:  2022-09-29

3.  Changes in cardiorespiratory function and fatigue following 12 weeks of exercise training in women with systemic lupus erythematosus: a pilot study.

Authors:  Sarfaraz Hasni; Li Rebekah Feng; Marquis Chapman; Sarthak Gupta; Anam Ahmad; Adam Munday; Mir Ali Mazhar; Xiaobai Li; Shajia Lu; Wanxia Li Tsai; Massimo Gadina; Michael Davis; Jun Chu; Zerai Manna; Shuichiro Nakabo; Mariana J Kaplan; Leorey Saligan; Randall Keyser; Leighton Chan; Lisa M K Chin
Journal:  Lupus Sci Med       Date:  2022-10

4.  Physical Fitness Attenuates the Impact of Higher Body Mass and Adiposity on Inflammation in Women With Systemic Lupus Erythematosus.

Authors:  Sergio Sola-Rodríguez; José Antonio Vargas-Hitos; Blanca Gavilán-Carrera; Antonio Rosales-Castillo; Raquel Ríos-Fernández; José Mario Sabio; Alberto Soriano-Maldonado
Journal:  Front Immunol       Date:  2021-10-14       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.